When.com Web Search

  1. Ads

    related to: atenolol forgetfulness dose for anxiety disorder

Search results

  1. Results From The WOW.Com Content Network
  2. Atenolol - Wikipedia

    en.wikipedia.org/wiki/Atenolol

    The beta-blocking effects of atenolol, as measured by reduction of exercise-related tachycardia, are apparent within 1 hour and are maximal within 2 to 4 hours following a single oral dose. [4] The general effects of atenolol, including beta-blocking and antihypertensive effects, last for at least 24 hours following oral doses of 50 or 100 mg ...

  3. Anxiolytic - Wikipedia

    en.wikipedia.org/wiki/Anxiolytic

    Anxiety is a naturally-occurring emotion and response. When anxiety levels exceed the tolerability of a person, anxiety disorders may occur. People with anxiety disorders can exhibit fear responses, such as defensive behaviors, high levels of alertness, and negative emotions.

  4. Adrenergic neuron blockers - Wikipedia

    en.wikipedia.org/wiki/Adrenergic_neuron_blockers

    The first-dose reaction can also result in tachycardia and orthostatic hypotension, which is characterised by a feeling of extreme dizziness that gets worse with an upright posture. [1] Intravascular volume reduction , or concomitant use of other antihypertensive drugs can also lead to reflex tachycardia and orthostatic hypotension .

  5. Just 100 micrograms of MM120 led to a 48% rate of remission from generalized anxiety disorder after 12 weeks, MindMed reported. Single dose of LSD can cut anxiety in half within weeks ...

  6. Is My Memory Loss Normal...Or An Early Sign Of Alzheimer's? - AOL

    www.aol.com/memory-loss-normal-early-sign...

    The earliest warning signs of Alzheimer's disease include memory loss that impacts your daily functioning, vision and language issues, social withdrawal, and more.

  7. List of investigational social anxiety disorder drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_investigational...

    This is a list of investigational social anxiety disorder drugs, or drugs that are currently under development for clinical use in the treatment of social anxiety disorder (SAD; or social phobia) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.